Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Veterans Affairs was posted on June 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Fluorouracil RFP

Closed
36E79726R0024Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs, through its National Acquisition Center, is soliciting bids for Fluorouracil 5% Cream under solicitation number 36E79726R0024, titled 6505--Fluorouracil RFP, in accordance with FAR Part 12 as a commercial item procurement. This unrestricted contract aims to secure an uninterrupted supply of 126,107 tubes of Fluorouracil 5% Cream, each containing 40 grams, for distribution to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Pharmaceutical Prime Vendor Programs. The contract term includes one base year and four pre-priced one-year option periods, with the requirement that all drug products must bear a unique NDC number and be labeled exactly as the name appears on the official product label. Glass packaging is strictly prohibited, and offerors must ensure compliance with these specifications to be considered. Proposals must be submitted electronically via SAM.gov by the deadline of June 22, 2026, at 2:30 p.m. Central Time, with no paper copies available or accepted. The award will be made to the responsible offeror capable of guaranteeing continuous, reliable supply, with no set-asides or preference programs applied. All inquiries should be directed to Contract Specialist Amber Zavala at [email hidden] or [phone hidden], located at the VA office in Hines, Illinois, 60141. Offerors are advised to monitor the SAM.gov portal continuously for any amendments or updates to the solicitation.

General Info

VA seeks single contract for Fluorouracil 5% Cream, one-year plus four option periods.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

3

Amendment 0001 to RFP 36E79726R0024 - Due Date Extension

DOCX, High priority: read this firstamendment
High

RFP 36E79726R0024 Fluorouracil 5% Cream

DOCX, High priority: read this firstrfp
High

Solicitation 36E79726R0024 for Fluorouracil 5% Cream

DOCX, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

Response deadline changed from Jul 1, 2026 to Jul 8, 2026. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Amber ZavalaContract Specialist

Full Description

Show more
n/a

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

6 days ago

DEADLINE

in 6 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 2 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS